We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Expert Opinion / Interview · May 29, 2014

Dry Eye Diagnosis and Management

Interview by
Kathleen F. Freeman OD, FAAO
Interview with
Kelly Nichols OD, MPH, PhD

 

Additional Info

  1. Perry HD, Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction, Cornea, 2006, Feb; 25(2):171-175

  2. Schechter BA, Efficacy of topical cyclosporine for the treatment of ocular rosacea, Adv Ther, 2009; 26(6): 651-659

  3. Rubin M, Efficacy of topical cyclosporine 0.05% in the treatment of posterior blepharitis, J Oc Pharmacol Ther, 2006; 22: 47-53

Further Reading